Revolution Medicines, Inc. (RVMD)

Revolution Medicines Statistics

Total Valuation

RVMD has a market cap or net worth of $18.74 billion. The enterprise value is $17.23 billion.

Market Cap	18.74B
Enterprise Value	17.23B

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026, after market close.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

RVMD has 193.32 million shares outstanding. The number of shares has increased by 15.98% in one year.

Current Share Class	193.32M
Shares Outstanding	193.32M
Shares Change (YoY)	+15.98%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	2.38%
Owned by Institutions (%)	92.94%
Float	173.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	11.52
P/TBV Ratio	12.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.05, with a Debt / Equity ratio of 0.26.

Current Ratio	8.05
Quick Ratio	7.86
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-84.35

Financial Efficiency

Return on equity (ROE) is -60.76% and return on invested capital (ROIC) is -35.37%.

Return on Equity (ROE)	-60.76%
Return on Assets (ROA)	-32.29%
Return on Invested Capital (ROIC)	-35.37%
Return on Capital Employed (ROCE)	-51.69%
Weighted Average Cost of Capital (WACC)	9.54%
Revenue Per Employee	n/a
Profits Per Employee	-$1.19M
Employee Count	809
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-753,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +136.93% in the last 52 weeks. The beta is 0.99, so RVMD's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	+136.93%
50-Day Moving Average	88.92
200-Day Moving Average	54.38
Relative Strength Index (RSI)	46.55
Average Volume (20 Days)	5,699,733

Short Selling Information

The latest short interest is 14.22 million, so 7.35% of the outstanding shares have been sold short.

Short Interest	14.22M
Short Previous Month	15.31M
Short % of Shares Out	7.35%
Short % of Float	8.17%
Short Ratio (days to cover)	3.06

Income Statement

Revenue	n/a
Gross Profit	-880.49M
Operating Income	-1.04B
Pretax Income	-961.73M
Net Income	-960.98M
EBITDA	-1.03B
EBIT	-1.04B
Earnings Per Share (EPS)	-$5.19

Balance Sheet

The company has $1.93 billion in cash and $414.97 million in debt, with a net cash position of $1.52 billion or $7.84 per share.

Cash & Cash Equivalents	1.93B
Total Debt	414.97M
Net Cash	1.52B
Net Cash Per Share	$7.84
Equity (Book Value)	1.60B
Book Value Per Share	8.42
Working Capital	1.73B

Cash Flow

In the last 12 months, operating cash flow was -$761.79 million and capital expenditures -$15.29 million, giving a free cash flow of -$777.08 million.

Operating Cash Flow	-761.79M
Capital Expenditures	-15.29M
Free Cash Flow	-777.08M
FCF Per Share	-$4.02

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RVMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.98%
Shareholder Yield	-15.98%
Earnings Yield	-5.13%
FCF Yield	-4.15%

Analyst Forecast

The average price target for RVMD is $100.13, which is 3.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$100.13
Price Target Difference	3.28%
Analyst Consensus	Strong Buy
Analyst Count	16
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1